Improving Flexibility & Participant Engagement For Oncology Patients

When an oncology patient lives far away from a clinical research site, flexibility is crucial, often bolstering participation engagement when hurdles associated with schedules, transportation, or otherwise, are eased. By conducting a trial in a patient's own community, sponsors and sites have witnessed improvements in the recruitment and retention of more patients. In fact, almost 12% of MRN visits conducted in the last five years have been categorized as “out of hours,” meaning these visits were delivered outside the standard business hours window, including evenings and weekends, meeting the patients at the location and time of their choosing.

Enabling patient-centered trials through flexible care delivery options empowers sponsors to prioritize patient preferences. This approach offers oncology patients the invaluable opportunity to undergo treatment from the comfort of their homes, providing respite during physically, mentally, and emotionally challenging periods. By staying close to their loved ones, patients receive crucial support and benefit from home-based clinical trial visits. Recognizing the individuality of each trial, patient, and family, it is evident that a one-size-fits-all approach is not suitable.

During this webinar, featured speakers Caroline Potts, Vice President of Visit Delivery, MRN, and Helena Baker, Co-Founder and Advisor, Rare Disease Nurse Network share the reality of a standard clinical visit for an oncology patient and how that story can change with the introduction of patient-centric, community-based clinical trials.

Access the full webinar to gain insight into participant engagement and the realities of supporting oncology patients on their clinical trial journey.